is jardiance a glp-1 receptor agonist Do We Need to Withhold the New Medications (SGLT2 Inhibitors) or Ozempic (GLP-1 Agonists) Before Cardiac Catheterization? Jardiance vs Ozempic 2026: SGLT2

It's getting buzz for adding a sweet taste to packaged foods like candy, cereal, and sauces, and for potentially having metabolic health benefits, especially when it comes to blood sugar regulation

The findings were published in the Endocrine Journal

Serious adverse events are rare but can include pancreatitis or gallbladder issues

When a cardiologist's primary clinical mandate is preventing heart attacks and strokes, and a drug demonstrates 20% reduction in major cardiovascular events, that drug becomes a cardiovascular medicine rather than a metabolic medicine

The primary outcome was a composite of major adverse limb events, defined as peripheral artery disease (PAD), critical limb ischaemia, percutaneous transluminal angioplasty or peripheral bypass for PAD, and amputation

GLP-1 exerts its actions on target cells by binding to specific high affinity receptors